Rosiglitazone . maleate

Same activities as rosaglitazone (Prod. No. AG-CR1-3570) but different formulation. Antidiabetic, hypoglycemic agent. Potent and selective peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist. Potent insulin sensitizing agent binding to the PPAR receptors in fat cells and making the cells more responsive to insulin. Ameliorates insulin resistance. Improves blood pressure and vascular function. Enhances proliferation of endogenous neural progenitor cells (NPCs). Anti-inflammatory compound. Has controversial therapeutic effects on the cardiovascular system. Promotes adipocyte differentiation of mesenchymal stem cells (MSCs).

Price Not Available 1 g Rosiglitazone . maleate Supplier Page
Catalog Number AG-CR1-3571-G001
Alternative Name(s) BRL 49653C; Rosiglitazone XR; Avandia
Research Area Biochemicals, Inflammation, Metabolism, Stem Cell Research
Molecular Formula C18H19N3O3S . C4H4O4
CAS# 155141-29-0
Purity >98%
Inchi InChI=1S/C18H19N3O3S.C4H4O4/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15;5-3(6)1-2-4(7)8/h2-9,15H,10-12H2,1H3,(H,20,22,23);1-2H,(H,5,6)(H,7,8)/b;2-1-
Inchi Key SUFUKZSWUHZXAV-BTJKTKAUSA-N
SMILES OC(=O)C=C/C([O-])=O.C[NH+](CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1
Size 1 g
Supplier Page http://www.adipogen.com/ag-cr1-3571/rosiglitazone-maleate.html